A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 130,261 shares of DXCM stock, worth $10.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
130,261
Previous 262,672 50.41%
Holding current value
$10.5 Million
Previous $29.8 Million 70.69%
% of portfolio
0.04%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$64.0 - $116.06 $8.47 Million - $15.4 Million
-132,411 Reduced 50.41%
130,261 $8.73 Million
Q2 2024

Jul 30, 2024

SELL
$110.31 - $140.45 $60.9 Million - $77.5 Million
-552,024 Reduced 67.76%
262,672 $29.8 Million
Q1 2024

May 01, 2024

SELL
$114.22 - $140.1 $4.11 Million - $5.04 Million
-35,989 Reduced 4.23%
814,696 $113 Million
Q4 2023

Jan 24, 2024

BUY
$75.49 - $124.16 $168,418 - $277,000
2,231 Added 0.26%
850,685 $106 Million
Q3 2023

Oct 26, 2023

BUY
$86.06 - $137.93 $5.78 Million - $9.26 Million
67,146 Added 8.59%
848,454 $79.2 Million
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $6.41 Million - $7.46 Million
-56,968 Reduced 6.8%
781,308 $100 Million
Q1 2023

May 04, 2023

SELL
$104.0 - $122.92 $17.3 Million - $20.5 Million
-166,766 Reduced 16.59%
838,276 $97.4 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $5.35 Million - $7.73 Million
-63,005 Reduced 5.9%
1,005,042 $114 Million
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $1.44 Million - $1.77 Million
18,821 Added 1.79%
1,068,047 $86.3 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $5.19 Million - $10.1 Million
76,368 Added 7.85%
1,049,226 $78.2 Million
Q2 2022

Jul 26, 2022

BUY
$67.99 - $132.89 $47.7 Million - $93.3 Million
701,859 Added 258.99%
972,858 $72.5 Million
Q1 2022

May 10, 2022

BUY
$94.08 - $130.2 $6.16 Million - $8.53 Million
65,516 Added 31.88%
270,999 $139 Million
Q4 2021

Feb 08, 2022

BUY
$129.87 - $162.82 $1.03 Million - $1.29 Million
7,926 Added 4.01%
205,483 $111 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $2.61 Million - $3.5 Million
24,467 Added 14.14%
197,557 $108 Million
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $281,440 - $375,056
3,475 Added 2.05%
173,090 $73.9 Million
Q1 2021

May 13, 2021

BUY
$84.79 - $104.74 $1.75 Million - $2.16 Million
20,654 Added 13.87%
169,615 $61 Million
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $5.47 Million - $7.33 Million
-70,149 Reduced 32.02%
148,961 $55.1 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $1.77 Million - $2.1 Million
18,572 Added 9.26%
219,110 $89.3 Million
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $8.61 Million - $14.5 Million
137,439 Added 217.81%
200,538 $81.3 Million
Q1 2020

May 12, 2020

BUY
$47.79 - $75.63 $388,198 - $614,342
8,123 Added 14.78%
63,099 $17 Million
Q4 2019

Feb 12, 2020

BUY
$36.62 - $57.29 $459,800 - $719,333
12,556 Added 29.6%
54,976 $12 Million
Q3 2019

Nov 12, 2019

SELL
$35.53 - $43.8 $759,027 - $935,699
-21,363 Reduced 33.49%
42,420 $6.33 Million
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $160,386 - $224,218
5,761 Added 9.93%
63,783 $9.56 Million
Q1 2019

May 13, 2019

SELL
$28.07 - $38.18 $494,424 - $672,502
-17,614 Reduced 23.29%
58,022 $6.91 Million
Q4 2018

Feb 11, 2019

SELL
$26.99 - $37.37 $397,265 - $550,049
-14,719 Reduced 16.29%
75,636 $9.06 Million
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $2.11 Million - $3.32 Million
90,355 New
90,355 $12.9 Million
Q3 2017

Nov 08, 2017

SELL
$11.36 - $18.98 $282,864 - $472,602
-24,900 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
24,900
24,900 $1.82 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.